Gamma Knife for Brain Metastases: Local Control, Dose and Sparing the Brain

Gamma Knife controls brain metastases in roughly 70 to 90% of treated lesions at one year, and the result depends strongly on the dose delivered to the edge of the tumour. Local control is about 92% when the margin dose is 21 Gy or more, and about 72% at 16 to 20 Gy¹. Radiosurgery alone is the usual choice for 1 to 4 metastases, chosen over whole-brain radiotherapy to spare memory and thinking, because it doses each spot rather than the whole brain².

When my acoustic neuroma was found I read everything I could about Gamma Knife, and metastases were the one indication that made me realise how differently this treatment behaves depending on why you need it. For a benign tumour like mine the question was slow control over years; for a secondary cancer it is about holding specific spots while the rest of the brain is protected. This article is the plain account of that difference, the one I wish had existed as a single page. For the full picture of the treatment itself, start with Gamma Knife radiosurgery, the pillar this sits under.

What are brain metastases and how does Gamma Knife treat them?

Brain metastases are tumours that have spread to the brain from a cancer elsewhere in the body, and Gamma Knife treats them by focusing a high dose of radiation on each individual spot while sparing the surrounding brain. Many weak beams of cobalt-60 gamma radiation converge on the target, so a treatment dose reaches a metastasis a few millimetres across without opening the skull and without a general anaesthetic³.

The word radiosurgery here describes a single high dose, delivered in one session; when the same idea is split over 2 to 5 sessions for a larger or awkwardly placed target it is called stereotactic radiotherapy⁴. Because each metastasis is dosed separately, the healthy brain in between is largely left alone, which is the whole reason radiosurgery is preferred to treating the entire brain. For how the beams actually converge, see how Gamma Knife works.

How effective is Gamma Knife for brain metastases?

Gamma Knife controls roughly 70 to 90% of treated metastases at one year, and that range is driven mainly by the dose to the edge of the tumour. In the study most often quoted, local control was about 92% when the margin dose was 21 Gy or more, and about 72% at 16 to 20 Gy, which is a large difference from a fairly small change in dose¹. Smaller metastases can take the higher dose more safely, which is part of why smaller and earlier tends to mean better control.

Control has a specific meaning here: the treated spot stops growing. It is not the same as cure, and it does not say anything about whether new metastases appear elsewhere in the brain, which is why follow-up imaging is careful and repeated². The treated tumour also often stays visible on scans for a while even when it is responding, so a single follow-up MRI is read alongside the ones before and after it, not on its own. For how that follow-up is structured, see Gamma Knife results and follow-up.

How many metastases can be treated, and when is whole-brain radiotherapy used instead?

Radiosurgery alone is the usual choice for 1 to 4 metastases, and modern practice increasingly treats more, guided by the total tumour volume rather than a simple count. Older guidance capped the number at about four per session; high-volume centres now safely treat beyond that, judging the decision on how much tumour there is in total rather than on how many separate spots³. The shift matters because a person with several tiny metastases may be a better candidate than someone with a single large one.

The alternative is whole-brain radiotherapy, which irradiates the entire brain over several sessions and can affect memory and thinking. Gamma Knife is the focal, brain-sparing option, with better local control of the treated spots². The trade-off is honest: radiosurgery does not treat the brain tissue where new, not-yet-visible metastases could appear, so it is paired with regular scans rather than pre-emptive treatment of the whole brain. NICE guidance for adults sets out where each approach fits⁵. The choice is compared in detail in Gamma Knife versus whole-brain radiotherapy, and the question of higher lesion counts in Gamma Knife for multiple brain metastases.

Can Gamma Knife treat the cavity left after surgery?

Yes: after a metastasis is removed by surgery, radiosurgery is often aimed at the cavity left behind to lower the chance of the tumour returning at that site. This is called treating the resection cavity, and it targets the surgical bed alone rather than irradiating the whole brain, keeping the memory-sparing advantage while cleaning up the microscopic tumour that surgery can leave at the margins⁵.

Surgery is generally chosen first when a metastasis is large, is causing pressure that needs relieving quickly, or when a tissue diagnosis is needed. Once it is out, the cavity is usually bigger than the original tumour and is dosed as its own target, sometimes with the dose split over a few sessions because of its size. This pairing, surgery then focused radiosurgery to the cavity, is one of the more common ways Gamma Knife is used for metastases, and it sits alongside the broader comparison in Gamma Knife versus surgery.

Am I a candidate, and what does the day involve?

Suitability depends on the size, number and position of the metastases and on the state of the cancer overall, and it is decided by a team looking at your scans. Single-session radiosurgery suits targets around 3 to 3.5 cm or smaller (about 10 to 15 cc in volume); larger ones are staged or fractionated, or removed by surgery first². The number of lesions is weighed as total volume rather than a hard count, as above.

The day itself is a day-case: a lightweight frame fixed to the skull with four pins after local anaesthetic (you feel pressure, not pain), imaging of about 30 minutes, a planning wait of one to several hours while the team works out the dose, then delivery of about 30 minutes to 2 hours, and home the same day³. The long middle wait during planning was the part of my own day nobody had warned me about, and it is worth knowing to expect it. For the honest hour-by-hour, see the day of Gamma Knife hour by hour and, if you are weighing your options, am I a candidate for Gamma Knife.

What are the risks for brain metastases specifically?

Early side effects are usually mild and short-lived; the delayed effect that matters most is radiation necrosis, roughly 5 to 25%, driven mainly by lesion size over 20 mm and by the dose. Necrosis is often manageable, for example with steroids or bevacizumab, and it can look like tumour regrowth on a scan, which is one reason follow-up is so careful³. Distinguishing the two sometimes takes repeat imaging over months rather than a single verdict.

The more common early effects are fatigue, headache, some brain swelling (oedema) managed with corticosteroids, and, for frame-based treatment, brief pin-site soreness. A second tumour caused by the radiation is very rare, on the order of well under 1% over many years, and is not a leading concern for metastasis treatment². For the calm, full explanation of the delayed effect, see radiation necrosis, what I learned and the broader Gamma Knife risks and side effects.